It is important to acknowledge here that translation and commercialisation are not new to HKUMed. We have had many successes over the years. Our main goal now is to build on those foundations and escalate this activity. I was personally involved in a recent successful example where our team collaborated with scientists from the University of Cambridge to develop a new stem cell platform that can help to personalise treatments for patients with rare forms of immunodeficiency. Our five InnoHK centres are also highly collaborative and had many achievements over the past year, including six spin-off companies, multiple awards at the 49th International Exhibition of Inventions of Geneva, and more than 10 patents published. These centres are working with top researchers from various disciplines around the world on key discoveries related to things like cancer, infectious diseases, vaccines, stem cells and big data in health. One final highlight in research that I would like to acknowledge is the generosity of our donors in supporting our research endeavours, which allows us to further our work in new directions. This past year, we were very fortunate to receive an exceptional pledge of HK$200 million from Mrs May Tam for advancing research on neuroscience and cancer and related community engagement. Mrs Tam has been very supportive of our Faculty over the years and she can trust that we will make every penny count. 15
RkJQdWJsaXNoZXIy Mzg4NDg0